Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,813.52
(
-0.16%
)
US TECH 100
24,405.20
(
-0.01%
)
Dow Jones
47,932.90
(
-0.52%
)
Brent Oil
92.68
(
-1.88%
)
Bitcoin
73,133.99
(
1.87%
)
News Focus
News Focus
Post# of 257375
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122860
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ronpopeil post# 233307

Wednesday, 01/19/2022 9:33:49 AM

Wednesday, January 19, 2022 9:33:49 AM

Post# of 257375
UCB.BR acquires ZGNX for $26.00/sh cash—a 66% premium to yesterday’s close:

https://finance.yahoo.com/news/ucb-acquire-zogenix-060000850.html

There is also a $2.00/sh (non-tradable) CVR based on EU approval of Fintepla by 12/31/23. (Fintepla was approved by the FDA in Jun 2020.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today